Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics RegisterEoghan McCarthy, Emily Sutton, Stephanie Nesbit et al.|Lara D. Veeken|2017Cited by 94
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensusFrancesca Ingegnoli, Valentina Messiniti, C. Baines et al.|Lara D. Veeken|2020Cited by 41
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprineJohn A. Reynolds, Caroline Gordon, Mary Gayed et al.|Lara D. Veeken|2022Cited by 20
O58. Longterm Outcomes of Children Born to Mothers with SLE Exposed to Hydroxychloroquine in PregnancyMary Gayed, Caroline Gordon, Munther A. Khamashta et al.|Lara D. Veeken|2014Cited by 8
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and WalesEoghan McCarthy, Emily Sutton, Stephanie Nesbit et al.|Lara D. Veeken|2017Cited by 4